Resveratrol suppresses neuroinflammation to alleviate mechanical allodynia by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway in a rat model of spinal cord injury

BackgroundNeuropathic pain (NP) is one of intractable complications of spinal cord injury (SCI) and lacks effective treatment. Resveratrol (Res) has been shown to possess potent anti-inflammatory and anti-nociceptive effects. In this study, we investigated the analgesic effect of Res and its underly...

Full description

Bibliographic Details
Published in:	Frontiers in Molecular Neuroscience
Main Authors:	Jie Han, Zhen Hua, Wen-jie Yang, Shu Wang, Fang Yan, Jun-nan Wang, Tao Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	neuropathic pain spinal cord injury resveratrol Janus kinase 2/signal transducer and activator of transcription 3 neuroinflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2023.1116679/full

Similar Items

Mechanism of Action of Exercise in Regulating Spontaneous Hypertension through the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway
by: Yu Li, et al.
Published: (2025-04-01)

Compact Impedance Matching Circuit for Wideband Power Transfer in Janus Helmholtz Transducers
by: Kibae Lee, et al.
Published: (2025-04-01)

Protective effect of abscisic Acid in a spinal cord injury model mediated by suppressed neuroinflammation
by: Maryam Rezaeezadeh Roukerd, et al.
Published: (2022-11-01)

Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer’s Disease
by: Xinxin Wang, et al.
Published: (2020-03-01)

Fatty Acid Binding Protein-4 Silencing Inhibits Ferroptosis to Alleviate Lipopolysaccharide-induced Injury of Renal Tubular Epithelial Cells by Blocking Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling
by: Suo Xu, et al.
Published: (2024-01-01)

Non-Coding RNAs Regulate Spinal Cord Injury-Related Neuropathic Pain via Neuroinflammation
by: Zhu J, et al.
Published: (2023-06-01)

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System
by: Satoshi Kubo, et al.
Published: (2018-06-01)

Protective Effect of Shenfu Injection against Sepsis-induced Acute Lung Injury by Suppressing Inflammation and Apoptosis Through the Regulation of the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway
by: Li-Juan Cao, et al.
Published: (2024-12-01)

Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
by: Huang Penghui, et al.
Published: (2024-05-01)

Janus kinases: dermatological perspective, a review
by: Hanan R Nada, et al.
Published: (2020-01-01)

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
by: Huo R, et al.
Published: (2022-04-01)

MicroRNA-122 protects against interferon-α-induced hepatic inflammatory response via the Janus kinase–signal transducer and activator of transcription pathway
by: Fanwei Liu, et al.
Published: (2025-01-01)

Inhibition of NF-κB Signaling Pathway by Resveratrol Improves Spinal Cord Injury
by: Luyao Xu, et al.
Published: (2018-10-01)

Electroacupuncture stimulation inhibited astrogliosis and microglia polarisation to alleviate spinal cord injury via Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway
by: Jianuo Li, et al.
Published: (2025-04-01)

The effect of combined resveratrol and nitric oxide treatment on the prevention of spinal cord ischemia-reperfusion injury: An experimental study
by: Kaptanıderya Tayfur, et al.
Published: (2020-03-01)

High mobility group box 1 induces the activation of the Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in pancreatic acinar cells in rats, while AG490 and rapamycin inhibit their activation
by: Guoliang Wang, et al.
Published: (2016-11-01)

Interferon-γ induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway
by: Shuhei Yoshida, et al.
Published: (2021-12-01)

Janus kinase inhibitors: between prescription authorization and reimbursability
by: F.R. Spinelli, et al.
Published: (2023-12-01)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022-07-01)

Janus Kinase inhibitors in dermatology: a review
by: Bárbara Vieira-Granja, et al.
Published: (2023-01-01)

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM)
by: Christopher Kemper, et al.
Published: (2022-06-01)

Iridoids derived from Valeriana jatamansi Jones alleviates neuroinflammation and blood spinal cord barrier permeability after spinal cord injury by activating the Nrf2/HO-1 signaling pathway
by: Yongzhi He, et al.
Published: (2025-07-01)

Multi-targeted nanogel drug delivery system alleviates neuroinflammation and promotes spinal cord injury repair
by: Penghui Wang, et al.
Published: (2025-04-01)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023-02-01)

Resveratrol Analogues as Selective Estrogen Signaling Pathway Modulators: Structure–Activity Relationship
by: Paulina Kobylka, et al.
Published: (2022-10-01)

Structural basis of Janus kinase trans-activation
by: Nathanael A. Caveney, et al.
Published: (2023-03-01)

Intrathecal lactate dehydrogenase A inhibitors FX11 and oxamate alleviate chronic constriction injury-induced nociceptive sensitization through neuroinflammation and angiogenesis
by: Hao-Jung Cheng, et al.
Published: (2024-11-01)

Pelargonidin improves functional recovery and attenuates neuropathic pain following spinal cord injury in rats: relevance to its neuroprotective, antioxidant, and anti-inflammatory effects
by: Leila Kooshki, et al.
Published: (2025-03-01)

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)

Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
by: Jonathan D. Ravid, et al.
Published: (2022-01-01)

Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors
by: L Xiao, et al.
Published: (2017-09-01)

Over Activation of IL-6/STAT3 Signaling Pathway in Juvenile Dermatomyositis
by: Qi Zheng, et al.
Published: (2024-07-01)

Research Progress on the Regulation of Resveratrol on Alzheimer’s Disease
by: WU Liangwen, ZHANG Hu, WU Tong, CHEN Ning
Published: (2023-02-01)

Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial
by: David E. Spaner, et al.
Published: (2019-04-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

Neurological recovery and antioxidant effects of resveratrol in rats with spinal cord injury: a meta-analysis
by: Bao-Ping Xu, et al.
Published: (2020-01-01)

The Upadacitinib - New Janus Kinase Inhibitor - Literature Review
by: Michalina Grzelka, et al.
Published: (2024-08-01)

Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
by: Danli Zhou, et al.
Published: (2019-04-01)

Fumagillin Attenuates Spinal Angiogenesis, Neuroinflammation, and Pain in Neuropathic Rats after Chronic Constriction Injury
by: Zhi-Hong Wen, et al.
Published: (2021-09-01)